Showing results (1801-1810 of 2,870) with videos related to

Sort By:
Pageof 287
JACC. Cardiovascular Interventions|July 26, 2014
Fractional flow reserve calculation from 3-dimensional quantitative coronary angiography and TIMI frame count: a fast computer model to quantify the functional significance of moderately obstructed coronary arteriesShengxian Tu, Emanuele Barbato, Zsolt Köszegi, et al.
JACC. Cardiovascular Interventions|July 26, 2014
Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve)Rebecca T Hahn, Philippe Pibarot, John Webb, et al.
JACC. Cardiovascular Interventions|August 23, 2014
A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trialSunil V Rao, Connie N Hess, Britt Barham, et al.
JACC. Cardiovascular Interventions|August 23, 2014
Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosisSeung-Jung Park, Jung-Min Ahn, Soo-Jin Kang, et al.
JACC. Cardiovascular Interventions|August 23, 2014
Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patientsMartin J Swaans, Annelies L M Bakker, Arash Alipour, et al.
JACC. Cardiovascular Interventions|August 23, 2014
Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defectAlexander J Javois, Jonathan J Rome, Thomas K Jones, et al.
JACC. Cardiovascular Interventions|August 23, 2014
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trialSammy Elmariah, Anthony J Furlan, Mark Reisman, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trialPatrick W Serruys, Vasim Farooq, Bindu Kalesan, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)J Matthew Brennan, Jeptha P Curtis, David Dai, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trialsWassef Karrowni, Ankur Vyas, Bria Giacomino, et al.
Pageof 287